Zyprexa documents ppt 2.

1
Zyprexa documents ppt 2.

• This powerpoint has a selection of pages from
  documents to do with marketing issues.

2
ZY 100175096Viva Zyprexa
3
ZY 100175096 Viva ZyprexaPCPs/GPs financial
opportunities
4
ZY 100175096 Viva ZyprexaUnmet
needs/disease-mongering
5
ZY 100175096 Viva ZyprexaUnmet
needs/disease-mongering
6
ZY 100175096 Viva ZyprexaUnmet
needs/disease-mongering
7
ZY 100175096 Viva ZyprexaUnmet
needs/disease-mongering
8
ZY 100175096 Viva ZyprexaIncentives to sales reps
9
ZY 100175096 Viva ZyprexaPhysician type casting
targeting
10
ZY 100175096 Viva ZyprexaPhysician CME strategy

11
ZY 100175096 Viva ZyprexaHave the customers
got the message?
12
ZY 100175096 Viva Zyprexastudying and utilising
the customers
13
ZY 100175096 Viva Zyprexa

• To the tune of
• Viva Las Vegas

14
ZY100040517 Primary Care sales video
15
ZY100040517 Primary Care sales video
16
ZY100040517 Primary Care sales video
17
ZY100040517 Primary Care sales video
18
ZY100040668 PCP strategy manual
19
ZY100040668 PCP strategy manual
20
ZY100040668 PCP strategy manual
21
ZY100040668 PCP strategy manual
22
ZY100040668 PCP strategy manual
23
ZY200307990 Lilly exec comments to media re
off-label marketing dwarfing schizophrenia
opportunities plus media comments re CME
newspaper article Mar 2003
24
ZY200307990 Lilly exec comments to media re
off-label marketing dwarfing schizophrenia
opportunities plus media comments re CME
newspaper article Mar 2003
25
ZY200307990 Lilly exec comments to media re
off-label marketing dwarfing schizophrenia
opportunities plus media comments re CME
newspaper article Mar 2003
26
ZY200307990 Lilly exec comments to media re
off-label marketing dwarfing schizophrenia
opportunities plus media comments re CME
newspaper article Mar 2003
27
ZY100520636 Primary care implementation guide
June 2001
28
ZY100520636 Primary care implementation guide
June 2001
29
ZY100520636 Primary care implementation guide
June 2001
30
ZY100520636 Primary care implementation guide
June 2001
31
ZY100520636 Primary care implementation guide
June 2001
32
ZY100520636 Primary care implementation guide
June 2001
33
ZY100520636 Primary care implementation guide
June 2001
34
ZY201220087 APA 2002 preparation
35
ZY201220087 APA 2002 preparation
36
ZY201220087 APA 2002 preparation
37
ZY201220087 APA 2002 preparation
38
ZY201220087 APA 2002 preparation
39
ZY201558654 Competitive literature review May
2002

• Document includes numerous studies by independent
  researchers and competitor pharma companies re
  hypergylcaemia, diabetes and hyperlipidaemia.
• Are reviewed in (hyper)critical manner to be
  found in error.
• Underlying theory seems to be Zyprexa cant cause
  these problems.

40
ZY201220087 APA 2002 preparation
41
ZY100014182 APA 2003 review